actinium pharmaceuticals inc
(ATNM:Consolidated issues listed on NYSE MKT LLC)
Sergio Traversa PharmD, MBA
Director, Actinium Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Dr. Sergio Traversa, PharmD, MBA has been the Chief Executive Officer at Relmada Therapeutics, Inc. since April 18, 2012. Dr. Traversa has over twenty-five years of experience in the healthcare sector in the United States and Europe, ranging from management positions in the pharmaceutical industry to investing and strategic advisory roles. Dr. Traversa served as the Interim Chief Financial Officer of Actinium Pharmaceuticals, Inc. since March 11, 2013 and also served ...
546 Fifth AvenuePhone: 646-459-4201
New York, New York 10036
Board Members Memberships*
Chief Executive Officer and Director
New York University - Leonard N. Stern School of Business
Universita' degli Studi di Torino
|There is no Competitor Compensation data available.|